Molecular Partners AG
MLLCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $8,328 | $0 | $0 | $0 |
| Gross Profit | -$8,328 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $8,328 | $10,706 | $11,921 | $10,549 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,602 | $3,994 | $4,221 | $3,826 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $115 | $2,617 | $0 | $419 |
| Operating Expenses | $12,045 | $17,317 | $16,142 | $14,794 |
| Operating Income | -$12,045 | -$17,317 | -$16,142 | -$14,794 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $209 | -$3,081 | -$630 | $3,564 |
| Pre-Tax Income | -$11,836 | -$20,398 | -$16,772 | -$11,230 |
| Tax Expense | $0 | $0 | -$2 | $2 |
| Net Income | -$11,836 | -$20,398 | -$16,771 | -$11,232 |
| % Margin | – | – | – | – |
| EPS | -0.32 | -0.56 | -0.45 | -0.34 |
| % Growth | 42.9% | -24.4% | -32.4% | – |
| EPS Diluted | -0.32 | -0.56 | -0.45 | -0.34 |
| Weighted Avg Shares Out | 37,399 | 37,392 | 36,875 | 33,194 |
| Weighted Avg Shares Out Dil | 37,399 | 37,392 | 36,875 | 33,194 |
| Supplemental Information | – | – | – | – |
| Interest Income | $366 | $420 | $502 | $651 |
| Interest Expense | $3 | $4 | $5 | $6 |
| Depreciation & Amortization | $527 | $553 | $552 | $570 |
| EBITDA | -$11,306 | -$19,841 | -$16,215 | -$10,654 |
| % Margin | – | – | – | – |